Stephen Bloch is the founder of EvolveImmune Therapeutics. EvolveImmune Therapeutics has raised $35M in total funding. Latest round: Series A.
Stephen Bloch, MD, is a veteran Connecticut venture capitalist who co-founded and currently serves as the CEO of EvolveImmune Therapeutics. His company focuses on using CRISPR gene-editing technology for developing drugs to treat cancer and autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide